AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Patient Eligibility and Challenges in Transplantation and Immunotherapies for AML
This chapter explores the patient population most suitable for transplantation and immunotherapies in AML, highlighting the exclusion of TP53 complex curio types and the challenges posed by the immunosuppressive microenvironment for CAR-T therapy. It proposes an innovative allergen egg type product and the importance of a tailored approach for this specific group.